42
Participants
Start Date
December 20, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Computed Tomography
Undergo CT or PET/CT
Fludeoxyglucose F-18
Given IV
Intensity-Modulated Radiation Therapy
Undergo IMRT
Magnetic Resonance Imaging
Undergo MRI
Peposertib
Given PO
Positron Emission Tomography
Undergo PET/CT
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYU Langone Hospital - Long Island, Mineola
Highland Hospital, Rochester
University of Rochester, Rochester
Inova Schar Cancer Institute, Fairfax
Medical University of South Carolina, Charleston
Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Moffitt Cancer Center, Tampa
The James Graham Brown Cancer Center at University of Louisville, Louisville
Ohio State University Comprehensive Cancer Center, Columbus
Sanford Cancer Center Oncology Clinic, Sioux Falls
Carle Cancer Center, Urbana
Carle at The Riverfront, Danville
Carle Physician Group-Mattoon/Charleston, Mattoon
Carle Physician Group-Effingham, Effingham
University of Oklahoma Health Sciences Center, Oklahoma City
M D Anderson Cancer Center, Houston
Mayo Clinic Hospital in Arizona, Phoenix
Banner MD Anderson Cancer Center, Gilbert
Banner University Medical Center - Tucson, Tucson
University of Arizona Cancer Center-North Campus, Tucson
UC San Diego Moores Cancer Center, La Jolla
Stanford Cancer Institute Palo Alto, Palo Alto
Providence Portland Medical Center, Portland
Sanford USD Medical Center - Sioux Falls, Sioux Falls
Collaborators (1)
NRG Oncology
OTHER
National Cancer Institute (NCI)
NIH